27/05/2021

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited.

Matéria Original

Anterior

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Próxima

Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2